Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the field of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and gene editing are altering the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering promise for more curative treatment options.